AP Healthcare Inc. Share Price

Equities

A109960

KR7109960005

Pharmaceuticals

End-of-day quote Korea S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
599 KRW -0.66% Intraday chart for AP Healthcare Inc. -2.28% -23.11%

Financials

Sales 2022 9.6B 6.98M 581M Sales 2023 16.01B 11.64M 970M Capitalization 51.55B 37.48M 3.12B
Net income 2022 -5.61B -4.08M -340M Net income 2023 4.3B 3.13M 261M EV / Sales 2022 -1.5 x
Net cash position 2022 81.33B 59.13M 4.93B Net Debt 2023 3.51B 2.55M 213M EV / Sales 2023 3.44 x
P/E ratio 2022
-11.9 x
P/E ratio 2023
24 x
Employees 16
Yield 2022 *
-
Yield 2023
-
Free-Float 55.49%
More Fundamentals * Assessed data
Dynamic Chart
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Aprogen Healthcare & Games Inc. announced that it has received KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc. CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Aprogen Healthcare & Games Inc. announced that it has received KRW 20.000001189 billion in funding CI
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 20.000001189 billion in funding CI
Aprogen Healthcare & Games Inc. acquired an 89.86% stake in Aprogen, Inc. for KRW 2.2 billion. CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc. CI
Osung Advanced Materials Co., Ltd. cancelled the acquisition of an additional 3.5% stake in S-MAC CO., Ltd. from Aprogen Healthcare & Games Inc.. CI
More news
1 day-0.66%
1 week-2.28%
Current month-3.54%
1 month-11.91%
3 months-1.64%
6 months-36.68%
Current year-23.11%
More quotes
1 week
595.00
Extreme 595
655.00
1 month
592.00
Extreme 592
721.00
Current year
528.00
Extreme 528
840.00
1 year
528.00
Extreme 528
2 495.00
3 years
528.00
Extreme 528
6 225.00
5 years
528.00
Extreme 528
7 400.00
10 years
528.00
Extreme 528
30 791.67
More quotes
Managers TitleAgeSince
Comptroller/Controller/Auditor 68 -
Members of the board TitleAgeSince
Director/Board Member 57 -
Director/Board Member 68 -
More insiders
Date Price Change Volume
26/24/26 599 -0.66% 242,569
25/24/25 603 -4.13% 480,358
24/24/24 629 +0.96% 346,024
23/24/23 623 +1.47% 1,157,877
22/24/22 614 +0.16% 234,626

End-of-day quote Korea S.E., April 26, 2024

More quotes
Aprogen Healthcare & Games Inc is a Korea-based company engaged in the manufacture and sale of pharmaceutical products. The Company mainly operates in four business segments. The Pharmaceutical segment provides medicines for digestive system, integumentary, nutrients and tonics and antibiotic preparations. The Insulation segment provides insulation products for refineries and other plants. The Rental segment provides office and laboratory rental services. The Other segment mainly provides business support services.
More about the company
  1. Stock Market
  2. Equities
  3. A109960 Stock